The annual general meeting in InDex Pharmaceuticals Holding AB (publ) was held on Wednesday 1 June 2022.
The shareholders’ influence in the Company is exercised at general meetings, which, in accordance with the Swedish Companies Act, is the Company’s highest decision-making body. As the Company’s highest decision-making body, the general meeting may resolve upon every issue for the Company, not specifically reserved for another corporate body’s exclusive competence. Thus, the general meeting has a sovereign role over the Board of Directors and the Chief Executive Officer (CEO).
At ordinary (annual) general meetings, resolutions must be passed on adoption of the profit and loss account and balance sheet, allocation of the Company’s profit or loss, discharge from liability for the board of directors and the managing director, elections of members of the Board of Directors and auditor and on remuneration for the Board of Directors and the auditor. Shareholders also resolve other key matters regarding the Company, such as amendment of the Articles of Association, any new issue of shares, and so on. The format of the General Meeting is primarily governed by the Company’s Articles of Association.